Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review

Ono Pharmaceutical Co Ltd (4528) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is an immuno-oncology company that provides research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes medicines for the treatment of type II diabetes, overactive bladder, osteoporosis, cancer, chemotherapy-induced nausea and vomiting, osteoporosis, Alzheimer’s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others for the treatment of cancer. The company also offers products in various formulations such as capsules, patches, dry syrup, tablets, injections, and intravenous infusions. Ono Pharmaceutical has manufacturing facilities including Joto Product Development Center, Yamaguchi Plant, and Fujiyama Plant. It offers products in the Americas, Europe, and Asia. Ono Pharmaceutical is headquartered in Osaka, Japan.Ono Pharmaceutical Co Ltd Key Recent Developments

Apr 05,2024: Ono Pharmaceutical Announces on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers
Dec 19,2023: Biomed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Jul 28,2023: AstraZeneca Settles Patent Lawsuits with BMS for $510M
Jul 18,2023: ONO and AIXs Jointly Developed an AI System for Topic Extraction Analysis of Medical Articles

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Ono Pharmaceutical Co Ltd - Key Facts
Ono Pharmaceutical Co Ltd - Key Employees
Ono Pharmaceutical Co Ltd - Key Employee Biographies
Ono Pharmaceutical Co Ltd - Major Products and Services
Ono Pharmaceutical Co Ltd - History
Ono Pharmaceutical Co Ltd - Company Statement
Ono Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ono Pharmaceutical Co Ltd - Business Description
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
R&D Overview
Ono Pharmaceutical Co Ltd - Corporate Strategy
Ono Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Ono Pharmaceutical Co Ltd - Strengths
Ono Pharmaceutical Co Ltd - Weaknesses
Ono Pharmaceutical Co Ltd - Opportunities
Ono Pharmaceutical Co Ltd - Threats
Ono Pharmaceutical Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Ono Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 05, 2024: Ono Pharmaceutical Announces on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers
Dec 19, 2023: Biomed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
Jul 28, 2023: AstraZeneca Settles Patent Lawsuits with BMS for $510M
Jul 18, 2023: ONO and AIXs Jointly Developed an AI System for Topic Extraction Analysis of Medical Articles
Jun 07, 2023: Ono Pharmaceutical establishes OPhrs Co
Apr 18, 2023: ONO PHARMA USA announces 2023 Golden Ticket Competition in partnership with LabCentral and MBC BioLabs
Apr 07, 2023: Announcement on changes of the board of directors, audit & supervisory board members and corporate officers
Apr 07, 2023: Notice regarding complete settlement of lawsuit on patents relating to anti-PD-1/PD-L1 antibody
Feb 15, 2023: Support for Relief Efforts in the Earthquake in Turkey and Syria
Jan 16, 2023: Ono Pharmaceutical enters research deal with Monash University
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Ono Pharmaceutical Co Ltd, Key Facts
Ono Pharmaceutical Co Ltd, Key Employees
Ono Pharmaceutical Co Ltd, Key Employee Biographies
Ono Pharmaceutical Co Ltd, Major Products and Services
Ono Pharmaceutical Co Ltd, History
Ono Pharmaceutical Co Ltd, Other Locations
Ono Pharmaceutical Co Ltd, Subsidiaries
Ono Pharmaceutical Co Ltd, Key Competitors
Ono Pharmaceutical Co Ltd, Ratios based on current share price
Ono Pharmaceutical Co Ltd, Annual Ratios
Ono Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Ono Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Ono Pharmaceutical Co Ltd, Interim Ratios
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Ono Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Ono Pharmaceutical Co Ltd, Performance Chart (2020 - 2024)
Ono Pharmaceutical Co Ltd, Ratio Charts
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings